HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Frequently asked questions
What sector does Heartbeam Inc. Warrant (BEATW) operate in?
Heartbeam Inc. Warrant belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Heartbeam Inc. Warrant (BEATW) current stock price?
As of the latest data, Heartbeam Inc. Warrant stock price is $0.02, with a previous close of $0.02. Heartbeam Inc. Warrant lost -$0.00 in the last trading session, representing a -9.64% loss.
What is Heartbeam Inc. Warrant (BEATW) current market capitalization?
Heartbeam Inc. Warrant market cap is approximately 791.62 thousand.
What is Heartbeam Inc. Warrant (BEATW) Earnings Per Share (EPS)?
The trailing EPS is -$0.50.
What is Heartbeam Inc. Warrant (BEATW) EBITDA?
Heartbeam Inc. Warrant EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.09 million.
Does Heartbeam Inc. Warrant (BEATW) pay dividends?
No. Heartbeam Inc. Warrant does not pay a dividend.
What is Heartbeam Inc. Warrant (BEATW) beta (volatility) score?
Heartbeam Inc. Warrant has a beta of 0.270, indicating lower volatility than the overall market.
